Regeneron Pharmaceuticals Inc.
$REGN
Public valuation for Regeneron Pharmaceuticals Inc. (REGN). Fair value, signal, and key metrics — no sign-in required.
Current Price
$758.27
37% Undervalued
Fair Value Estimate
$1,039
💎
Value
Established company trading at a low multiple
Analyst Consensus
Target: $850.88
12% higher than current
Key Metrics
Market Cap
$78.1B
Forward P/E
14.5x
Operating Margin
30.1%
Revenue Growth
12.3%
PEG Ratio
1.04
Get free watchlist alerts
Join the waitlist for valuation updates on $REGN and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.